Physician profile
Brian Ching
NPI 1306945936
$1,449,543.78
in general payments reported to CMS, 2019-2025
17 companies · $4,337 in 2025
The $4,337 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159K · 2020: $1.1M · 2021: $119K · 2022: $157 · 2023: $366 · 2024: $47K · 2025: $4,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $50K · Food and Beverage: $940 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $49,896.77 |
| Food and Beverage | $940.13 |
| Travel and Lodging | $465.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $1,119,187.36 | 2020 | |
| Medtronic, INC. | $169,225.05 | 2021-2025 | Inpen Smart Insulin Delivery System, Biosyn |
| Medtronic Vascular, INC. | $84,005.09 | 2019 | |
| Medtronic USA, INC. | $74,158.11 | 2019 | |
| Zimmer Biomet Holdings, INC. | $2,396.59 | 2019-2025 | Oxford, Persona, Juggerknotless Soft Anchor |
| Pacira Pharmaceuticals Incorporated | $170.89 | 2023-2025 | Zilretta, Exparel, Iovera |
| Pacira Therapeutics, INC. | $76.74 | 2020-2021 | |
| Acell, INC. | $58.47 | 2019 | |
| Sonex Health, INC. | $56.57 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $47.35 | 2020-2022 | |
| Ethicon US, LLC | $42.35 | 2021-2025 | Ethicon, Dermabond Prineo, Vistaseal |
| Depuy Synthes Sales INC. | $40.65 | 2022-2023 | Orthovisc, Monovisc |
| Mallinckrodt Enterprises LLC | $24.18 | 2019 | |
| Heron Therapeutics, INC. | $22.70 | 2024 | Zynrelef |
| Abbott Laboratories | $17.68 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $14.00 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$660,873.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.